Drugs of Congestive heart failure Flashcards

1
Q

CONGESTIVE HEART FAILURE(CHF)
- Occurs when ———— (———-) is inadequate
to provide —————-needed by the body.
CO = ——-(rate of contraction of heart) X ———–
(volume of blood ejected with each beat).

A

cardiac output(CO)
o2
HR X SV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HF occurs due to ———-cardiac
contractility or ———– preload and/or
afterload.

A

decreased-increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The patient has:

  • Low COP manifestations e.g., —-,—–,—-,—-,—-
  • Congestive manifestations e.g.,
  • —,—–,—-,—-,——
A

fatigue,
dizziness, cold hands, cyanosis, and syncope
leg oedema, congested liver, cough, dyspnea,
and pulmonary oedema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cardiac performance is a function of four
primary factors: ========,=======,=========,======
‡ ————: load on the heart created by the volume
of blood injected in the left ventricle (at the end of
diastole). It is a volume load.
‡ ———–: load on the contractile ventricle
created by the resistance to the blood injected into
the arterial system by the left ventricle i.e. total
peripheral resistance. Thus, it is a pressure load.
‡ ———–: the capacity of myocardial to
generate force to respond to preload and
overcome after load.
‡ ———–: a major determinant of cardiac output

A
Preload, after load, contractility&
heart rate (HR)
Preload
After load
Contractility
Heart rate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
-------------- blockers directly
affect the sympathetic
activity also it reduces
both preload and
afterload by working
on the kidney (inhibits
Renin release)
A

Beta1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
First we decrease
both preload and
afterload then we
work on the heart
activity(by-----------)
A

Digitalis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pathophysiogy of heart failure:
‡ They provide short term hemodynamic compensation for decreased CO but ultimately cause deterioration of
decompensated HF
1————- sympathetic activity:
‡ a- ———- Force of contraction
‡ b- ———–Heart rate
‡ c ————— of RAAS leads to : Vasoconstriction:
Venoconstriction————-preload
Arterioloconstriction————– afterload
2-Activation of RAAS: -
a-stimulate aldosterone ——-salt &water retention lead
——-preload
B- ————– of the heart & blood vessels.
C -Angiotensin II lead to VC ———preload &after load
3- Myocardial ————–

A
inc
inc
inc
stimulation
inc
inc
Remodeling
inc
hypertrophy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Functional classification
‡ Generally relies on the New York Heart
Association functional classification. The classes
(I-IV) are:
‡ Class I: no limitation is experienced in any
activities; there are ——— from ordinary
activities.
‡ Class II: ————-, mild limitation of activity; the
patient is comfortable at rest or with mild
exertion.
‡ Class III: marked limitation of any activity; the
patient is comfortable only ————–
‡ Class —-: any physical activity brings on
discomfort and symptoms occur at rest.

A

no symptoms
slight
at rest.
IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Therapeutic strategies:
‡ ————– physical activity
‡ ———- sodium intake
‡ treatment of comorbid conditions
‡ Use of diuretics,ACEIs &inotropic agents
‡ Avoid ———-,———-,——-, some drugs

A

Decrease
Decrease
NSAIDs,CCBs,alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chronic failure is best treated with ——– (———–) plus an —–, if tolerated, a ——–. Digitalis may be helpful if
systolic dysfunction is prominent.
- acute heart failure should be treated with a ——-; if severe, a prompt-acting positive inotropic agent
such as a———– or—————,
and ————– should be used as required to optimize
filling pressures and blood pressure.

A

diuretics(often loop agent plus spironolactone)+ ACE inhibitor- beta blocker-Digitalis

loop diuretic
beta agonist
phosphodiesterase inhibitor
vasodilators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Drugs used in heart failure :
Drugs reduce mortality working on remodeling
3 drugs
ABS

A
  • ACEIs
  • Beta blockers
  • Spironolactone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Drugs used in heart failure :

-Drugs improve symptoms

A
  • Digitalis(Digoxin)
  • Diuretics
  • Vasodilators (nitrates or hydralazine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

———— is the most effective drug in
treatment of H.F it decreases both
preload and afterload and prevents
deterioration of the heart.

A

ACE-I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
Angiotensin converting enzyme
inhibitors(ACEIs) e.g. captopril:
- Mechanism of action:
 Pharmacokinetics:
_Incompletely absorbed, must be taken on empty stomach (food decreased absorption).
_ -Excreted by ------------
A

Decreased Angiotensin II production& NE
release leading to:
‡ 1- Decreased preload &after load.
‡ 2- Decreased cardiac hypertrophy, dilatation
&remodeling.
‡ 3- Decrease HR or does not increase it.

empty
kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Adverse effects of ACEI:

7 things

A

1 - First dose hypotension (start with a small
dose at bed time).
2 -Acute angioedema & chronic dry cough (inc
BK).
3 -Hyperkalemia (potassium supplement or
spironolactone are CI).
4 -Renal impairment (in renal artery stenosis,
high renin states as CHF).
5 -Metallic taste (captopril), neutropenia in some
cases.
6 -Fetotoxic (CI in pregnancy).urinary abnormality
7-CI in Asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Angiotensin II type ———– receptor
blockers(ARBs):
‡ ———— is the prototype and differs from other
in that it ———– extensive 1st pass
metabolism.
‡ Mechanism of action:
‡ antagonizing angiotensin II ____———-preload and afterload
‡ Block AT1 receptors ____ vasodilatations
&antiproliferative action.
No increase in ————– so no
angioedema &cough.
Adverse effects: same as ACEIs
CI in ——————.

A
1
Losartan
undergoes
decrease
bradykinines
pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

2-Diuretics:
1 -Decrease blood volume ——–venous
return———- preload.
2 -Decrease CO————blood pressure ——–after
load
3 ————— are used in mild to moderate
cases while ———- diuretics are used in
sever, acute or in renal impairment

A

dec-dec-dec-dec
Thiazide
loop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

3- Beta blockers:
three members are recommended for use:
————, —————- and ————–.

A

carvedilol, bisoprolol and metoprolol

19
Q

Alpha and Beta blocker with antioxidant activity ?

A

Carvedilol

20
Q

Beta Blocker
Beneficial actions in——– mortality and
morbidity is due to; prevention of changes
due to chronic ————
stimulation,including ———– in
HR,inhibition of ———– release,———— of
deleterious effects of norepinephrine,
decreasing ————-,hypertrophy and cell
death (apoptosis).
used in ———– stages
Not given to ———— HF

A
reducing
sympathetic
decrease
renin
prevention
remodelling
acute
21
Q

Inotropic agents:
The only oral positive inotropic drug
available for chronic use

A

Digitalis or cardiac glycosides (digoxin):

22
Q

Digitalis or cardiac glycosides (digoxin):

Mechanism of myocardial contraction:

A
  • The force of contraction is directly
    proportional to the concentration of free
    intracellular (IC) calcium.
  • The amount of calcium sequestered in the SR
    is dependent on the balance of calcium influx
    and calcium efflux.
23
Q
  • Mechanism of action of digitalis:
    A-Mechanical: Inhibits membrane bound Na+/K+
    ATPase_————— IC Na+ thus concentration gradient
    across the membrane ————– _____decrease the
    driving force for the Na+/Ca++ exchanger ___ decrease
    calcium expulsion and ——–IC Ca++
    -The concentration gradient for—— and ——- is the
    major determinant of the net movement of ions
    especially ———-.
    -The increased IC Na+ and Ca++ results in:
  • 1-increased myocardial contractility____—— EDV &_____ CO,
    tissue & renal perfusion ____—- renin secretion ____——— salt&water retention &induce diuresis___——- preload and after
    load.
  • 2- Decrease sympathetic activity____—– HR, oxygen
    demand, VC& renin secretion.
A
increase
decreases
increase 
Na+ and Ca++
Na+
dec
inc
dec
dec
dec
dec
24
Q

B- Electrical: autonomic stimulation (mainly
————–, sympathetic only in ———–
doses) decreasing HR which is a sign of
improvement
‡ Therapeutic uses: ———– with AF (due to
combined inotropic & bradycardic
effect).Also, sever HF after ACEIs, BBlocker &
diuretics. Mild to moderate cases do not
require————-.
‡ —————is an early sign of
improvement.

A
parasympathetic
toxic
HF
digoxin
Bradycardia
25
Q

‡ Pharmacokinetics:
‡ ———- has rapid onset &shorter
duration compared to digitoxin.
‡ -Has a high volume of distribution, used
in acute digitalization.
‡ -Widely distributed including CNS,
eliminated (2/3) unchanged through
kidney(dose adjustment is needed).
‡ ———– is extensively metabolized via
liver.
‡ -Narrow safety margin.

A

Digoxin - digitoxin

26
Q

patient has a kidney dysfunction can use ? ————- metabolized by ————–

A

Digitoxin

27
Q

patient has a live dysfunction can use ? ————- metabolized by ————–

A

Digoxin

28
Q

Digoxin CI

Absloute in

A

Ventricular arrhythmia
Hypertrophy obstructive cardiomyopathy (thickening intraventrieular septum) -Never give +ve inotropes or +ve chronotropes
Wolf Parkinson’s white syndrome
H-Block (-ve AV conduction) delay

29
Q

Digoxin CI

relative in

A
Patients with Brndycardia
On beta blockers
On Verapamil
Myodema= Hypothyroidism
Sick sinus syndrome (Low SA node rate)
Hyperactive carotid sinus

Systemic or Pulmonary H TN
So, give VD first before Digoxin such
C.C B ( not verapamil nor nifedipine) ive Amlodipine
NO brady,c NO Tachy_ C

Renal impairment (Digoxin toxicity)

Cardiovesion (arrhythmia)

MI (Increase infarct size)

Acute rheumatic fever myocarditis

30
Q

Digitalis or cardiac glycosides (digoxin):
‡ Adverse effects:
4 things

A
‡ 1- Cardiac dysrhythmias: all types
can be encountered:
‡ (Increased automaticity, and
increased vagal tone).
‡ 2-GIT(Early early sign of Toxcity): nausea, vomiting &diarrhea .
‡ 3- CNS(late late sign of Toxcity): confusion, hallucinations,
convulsions& colored vision(green
and yellow)
‡ 4- Gynecomastia due to its steroid
nucleus.
31
Q

Treatment of toxicity of Digitalis:

5 things

A

1 -Drug withdrawal with symptoms suggestive of
toxicity (GIT& visual).
2 -Potassium supplement (CI in heart block,
renal impairment). (K & digoxin inhibit each
binding to ATPase).
3 -Antidysrhythmic drugs to treat dysrhythmia.
4 - Digoxin immune fab (antibodies) which
inactivate the drug.
5 -Plasma pheresis: in renal failure since
digoxin AB can not be given as they would
accumulate.

32
Q

————–vs Digitalis

A

POTASSIUM

33
Q
  • Factors predisposing to digitalis toxicity:

4 things

A
1-Hypokalemia (K-losing diuretics
&corticosteroids), hypercalcemia,
hypomagnesaemia (magnesium opposes
calcium).
2-Antidysrhythmic drugs: verapamil,
amiodarone and quinidine ĺ displace
digoxin from tissues &compete for excretion.
3- Hypothyroidism and hypoxia.
4- Renal impairment
34
Q

cGMP > ———-

cAMP > ————–+—————-

A

V.D
V.D in Smooth ms , V.C
in myocardial ma

35
Q

Other positive inotropic agents:

A

1- Beta adrenoceptors agonists:
(direct)(emergency)a-Dobutamine: used in acute HF& given by IV
infusion (inc.cAMP___ phosphorylation of calcium
channels____ inc calcium entry into myocardium and
VD).
b-Dopamine: inc CO, inc renal blood flow &inc blood
pressure (depending on the dose_ stimulate
dopamine, beta or alpha receptors)
2-Phosphodiesterase inhibitors(indirect): Amrinone
&milrinone
___inc cAMP_____incIC calcium___-inc myocardial
contractility.
-Indicated for short term therapy___ rapid
tolerance, thrombocytopenia& hepatotoxicity.

36
Q

It causes smooth muscle relaxation, and increases heart contractility————-

A

-Phosphodiesterase inhibitors

37
Q

Used in acute
HF or
cardiogenic
shock———–

A

Dobutamine

38
Q

use only with acute CHF , for maximum 48h

———–

A

Phosphodiesterase inhibitors:

39
Q

Spironolactone:
-Small dose added to—,—–,—- _ decrease mortality by 30% due to prevention of ———– production__
decrease salt and water retention. Also,
counteracts ————- which
predisposes to digitalis toxicity & decreases
remodeling.
-Should not be taken with ————— or in
—————–.

A
ACEIs, diuretics&
digoxin-aldosterone
hypokalemia
potassium
renal impairment
40
Q

6- Vasodilators
- ———dilators as nitrates_dec preload by
shifting blood to venous capacitance vessels
(——–of whole vascular system) ĺ
dec congestive symptoms.
- Arteriolodilators:
- e.g. hydalazine_ dec peripheral resistance
dec after load _inc CO &tissue perfusion.
‡ Hydralazine should not be used alone (———+——-) _combined with
——————–.

A
Veno
80%
reflex
tachycardia& edema
nitrates
41
Q

Management of Acute Heart Failure
I. Management of Acute Pulmonary Edema
———– IV, ————— IV, ————- IV,
and Oxygen to control hypoxia
II. Restoring Hemodynamics
(———-COP
& tissue perfusion and maintain BP):
Drugs used differ according to level of the
systolic BP: ——, ——-, or ——-.

A
Frusemide
Nitroglycerin
Morphine
increase 
NE
Dobutamine
nitrates
42
Q

Diastolic dysfunction
ƒ CHF with preserved EF
ƒ Is best treated with:
β-blockers;

- Prevent tachycardia;
Maximizing diastolic filling)
- Reduce B.P and MI
- Promote regression of LV
Hypertrophy
- Associated with improved
survival
Diuretics
to reduce ---------------
A

preload

43
Q

Beta blocker treatment should not be:
• Prescribed without ————-in patients with current or recent history of fluid retention.
• Prescribed to patients with higher degree AV heart block, and should be used with caution in those with second degree AV block.
• Prescribed for initiation in patients with acute HF symptoms or ———— HF.
• If a non-cardioselective beta blocker (e.g., carvedilol)), prescribed to patients with significant asthma or bronchoconstrinction, especially if with a ——- methacholine challenge

A

diuretics
decompensated
positive